Early-Stage Investment Firm Allied Minds Funds U of Colorado Medical Device Startup | GenomeWeb
Investment firm Allied Minds said this month that it has invested an undisclosed amount in Illumasonix, a start-up company based on a non-invasive technology for quantifying blood flow developed by researchers at the University of Colorado.
The deal is the latest in a string of similar investments by two-year-old Allied Minds as the firm begins to cement itself as an option for universities to bridge the so-called “funding gap” for start-up companies based on nascent technologies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.